Search the Newsreel

Bruker Corporation (Nasdaq: BRKR) sets $3.9844 dividend on Series A preferred

Bruker Corporation declared a quarterly cash dividend of $3.9844 per share on its 6.375% Mandatory Convertible Preferred Stock, Series A, declared on July 30, 2026. The dividend is payable on September 1, 2026, to shareholders of record as of August 15, 2026. This action …

Bruker Corp (BRKR) Institutional Confidence

Bruker Corp (BRKR) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 91.74%, a slight decrease from the previous quarter. Steven Cohen is the largest institutional shareholder, holding 0.63% of …

Earnings Preview: Bruker Corp to Report Financial Results Pre-market on August 04

Bruker Corp (BRKR) is scheduled to release its financial results pre-market on August 4, 2026. Analysts are projecting earnings per share (EPS) of $0.66, with revenue expected to be $730.29 million. Investors will be keen to see if the company beats these estimates.

Bruker Corp (BRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Bruker Corp (BRKR), detailing its current risk score of 7.43, which ranks 39 out of 199 in the Healthcare Equipment & Supplies industry. It highlights the company's beta value of 1.24, indicating higher volatility compared to the …

Bruker Corp (BRKR) Financial Health: Profitability & Balance Sheet Analysis

Bruker Corp (BRKR) currently holds a financial score of 8.42, ranking 36 out of 199 in the Healthcare Equipment & Supplies industry, indicating a weak financial status but high operating efficiency. The company's latest quarterly revenue saw a 2.75% year-over-year increase, with net profit …

Bruker Corp (BKD) Q1 2026 Earnings Report - Results, Call & Slides

Bruker Corp (BKD) announced its Q1 2026 earnings, beating both EPS and revenue expectations. While the company faces near-term challenges like organic revenue declines and academic funding weaknesses, it reconfirmed its full-year 2026 guidance, citing strong bookings, AI-driven opportunities, and cost savings exceeding original …

Bruker Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, Bruker Corp. (NASDAQ: BRKR) has approximately 11,059 employees worldwide, representing a 0.6% growth since 2023 but a 1.2% decline year-over-year. The company, headquartered in Billerica, Massachusetts, is actively hiring, with 457 job postings in 2026, although hiring velocity has slowed. …

Bruker Corp (BRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Bruker Corp (BRKR), including its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The analysis suggests the stock is currently trading within a range, making it suitable for …

Bruker Corp (BRKR) Stock Up 4.8% and Still Undervalued -- GF Sco

Bruker Corp (BRKR) shares recently rose by 4.8% to $62.91, placing the stock in a fairly valued category according to its GF Value™ of $62.89. Despite a strong GF Score™ of 86/100, the company faces concerns regarding its cash-flow-negative status, low financial strength (5/10), …

Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Maintains Target Price $40

Goldman Sachs has reiterated its Sell rating on Bruker Corp (BRKR.US), keeping its target price unchanged at $40. This indicates a continued bearish outlook from the firm regarding the company's stock performance.

Eversept Partners LP Reduces Stock Position in Bruker Corporation $BRKR

Eversept Partners LP significantly reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 85.1% in the first quarter, selling over 666,000 shares. Despite this, other institutional investors have increased their holdings, and Bruker reported strong Q1 earnings, beating consensus estimates. The company provided a positive …

Bruker (BRKR) Expected to Announce Earnings on Tuesday

3 Reasons to Sell BRKR and 1 Stock to Buy Instead

3 Reasons to Sell BRKR and 1 Stock to Buy Instead Bruker's 26.8% return over the past six months has outpaced the S&P 500 by 20.6%, and its stock price has climbed to $60.45 per share. This was partly thanks to its solid quarterly …

Bruker Corp (BRKR) Cash Flow

This article provides a detailed quarterly and annual cash flow statement for Bruker Corp (BRKR), covering operating, investing, and financing cash flows, along with free cash flow data over several years. It includes key financial metrics, year-over-year percentage changes, and definitions of different cash …

Bruker Corp (BRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Bruker Corp (BRKR) by business segment and by region, using data updated on April 6. The company generates 80.50% of its revenue from products and 19.50% from services and other revenue. Geographically, the Rest of Europe …

London Co. of Virginia Has $93.34 Million Stock Holdings in Bruker Corporation $BRKR

London Co. of Virginia trimmed its stake in Bruker Corporation (NASDAQ:BRKR) by 7.2% in the first quarter, though it still holds over 2.5 million shares valued at approximately $93.3 million. Despite the reduction, institutional investors collectively own 79.52% of Bruker's stock. Analysts currently rate …

Bruker Corp (BRKR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Bruker Corp (BRKR), listing major shareholders and their proportionate holdings, including Laukien (Frank H), Orbis Investment Management Ltd., and Fidelity Management & Research Company LLC. It also provides a breakdown of shareholder types by proportion and tracks …

Press Release: Bruker Announces Date and Time of Second Quarter 2026 Earnings Release and Webcast

Bruker Corporation (Nasdaq: BRKR) has announced that it will release its second-quarter 2026 financial results after the market closes on Tuesday, August 2, 2026. This will be followed by a webcast and conference call at 4:30 PM Eastern Time on the same day, featuring …

A Look at Bruker Corp (BRKR) After 4.0% Gain -- GF Value $62.85 vs Price $62.15

Bruker Corp (BRKR) shares recently rose by 4.0% to $62.15. The company is currently considered 1.1% undervalued compared to its GF Value™ of $62.85, with a strong GF Score™ of 86/100, though its financial strength is noted as a potential concern. Insider selling has …

Bruker Corp | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans - moomoo

This document is an initial registration statement on Form S-8 filed by Bruker Corp. It pertains to securities being offered to employees through employee benefit plans. The filing indicates the company's compliance with regulatory requirements for employee stock offerings.

Bruker secures $10M in federally funded NMR orders from NYSBC, Delaware, and Northwestern

Bruker has secured over $10 million in federally funded orders for its advanced nuclear magnetic resonance (NMR) spectroscopy systems. These orders come from the New York Structural Biology Center (NYSBC), the University of Delaware, and Northwestern University, enhancing their research capabilities in areas like …

TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $60

TD Cowen has reiterated its Hold rating for Bruker Corp (BRKR.US) and increased its price target from $58 to $60. This adjustment in the price target suggests a continued cautious but slightly more optimistic outlook on the company's stock by the financial firm.

Bruker Corp exec Mark Munch sells $120,500 in shares

Mark Munch, Executive Vice President and President of Bruker Nano Inc., a subsidiary of Bruker Corp (NASDAQ:BRKR), sold 2,000 shares of company common stock for $120,500 on July 15, 2026, after exercising stock options. This sale was conducted under a Rule 10b5-1 trading plan. …

Bruker Corp (NASDAQ: BRKR) EVP Munch sells 2,000 shares under 10b5-1 plan

Mark Munch, an Executive Vice President at Bruker Corp (NASDAQ: BRKR), exercised stock options for 2,000 shares at $22.19 each and subsequently sold all 2,000 common shares at $60.25 per share through an open-market transaction under a Rule 10b5-1 trading plan. After these transactions, …

Goldman Sachs Maintains Bruker Corp(BRKR.US) With Sell Rating, Raises Target Price to $40

Goldman Sachs has maintained a Sell rating on Bruker Corp (BRKR.US) while raising its target price to $40. This article likely details the reasoning behind the revised target and sustained negative outlook from the analyst firm.

BRKR (NASDAQ: BRKR) holder plans July 2026 sale of 2,000 shares

Mark R. Munch, a holder of Bruker Corporation (NASDAQ: BRKR) shares, has filed a Form 144 notice to sell 2,000 common shares on or after July 15, 2026, through Morgan Stanley Smith Barney LLC. The proposed sale, which will be executed on NASDAQ, has …

Press Release: Bruker Expands Infection Detection Portfolio With Acquisition of Metagenomic MNGS DISQVER(R) Platform for Pathogenic Microorganisms in Blood

Bruker has acquired the Metagenomic MNGS DISQVER(R) platform to expand its infection detection portfolio. This acquisition integrates a advanced metagenomic next-generation sequencing (mNGS) workflow specifically for identifying pathogenic microorganisms in blood samples. The DISQVER platform aims to enhance Bruker's diagnostic capabilities by providing rapid …

Bruker acquires clinical metagenomics platform from Noscendo

Bruker Corporation has acquired the DISQVER clinical metagenomics platform from Noscendo GmbH, enhancing its next-generation sequencing-based infection detection capabilities. The platform, which analyzes microbes directly from blood samples and searches for over 11,000 different microbes, is currently for research use only, but Bruker is …

Bruker's Research-Only Platform Analyzes Blood in Under 24 Hours

Bruker (NASDAQ: BRKR) has acquired the DISQVER® platform, expanding its infection detection portfolio with metagenomic next-generation sequencing (mNGS) capabilities for pathogenic microorganisms in blood. This platform allows for rapid and comprehensive whole genome sequencing analysis directly from cell-free human blood samples in under 24 …